Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis

Clinical Colorectal Cancer

Volumn 16, Issue 4, 2017, Pages 252-263

  Zhang, Jianping ^a   Cheng, Zhiyuan ^a,b   Ma, Yubao ^a   He, Caili ^a   Lu, Yongbin ^a   Zhao, Yaxue ^a   Chang, Xiaoyu ^a   Zhang, Yawei ^b   Bai, Yana ^a   Cheng, Ning ^a  

^a LANZHOU UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colonoscopy; CRC; Incidence; Mortality

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COCHRANE LIBRARY; COLONOSCOPY; COLORECTAL CANCER; FECAL IMMUNOHISTOCHEMICAL TESTING; FLEXIBLE SIGMOIDOSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDLINE; META ANALYSIS; NETWORK META-ANALYSIS; OCCULT BLOOD; REVIEW; SIGMOIDOSCOPY; WEB OF SCIENCE; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; INCIDENCE; MASS SCREENING; PATHOLOGY; PROCEDURES;

COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MASS SCREENING; NETWORK META-ANALYSIS; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 85021710518     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2017.03.018     Document Type: Review

References (69)

1. Miller, K.D., Siegel, R.L., Lin, C.C., et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66 (2016), 271–289.
2. Lieberman, D.A., Clinical practice. Screening for colorectal cancer. N Engl J Med 361 (2009), 1179–1187.
3. Neugut, A.I., Lebwohl, B., Colonoscopy vs sigmoidoscopy screening: getting it right. JAMA 304 (2010), 461–462.
4. Basu, A., Martt, P., Comparison of diagnostic accuracy between immunochemical and guaiac based faecal occult blood tests for colorectal cancer detection: a systematic review of the literature. HSAC Report, 2, 2009.
5. Faivre, J., Dancourt, V., Lejeune, C., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126 (2004), 1674–1680.
6. Mandel, J.S., Bond, J.H., Church, T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993), 1365–1371.
7. Arbyn, M., Van, O.H., Lynge, E., et al. European Commission's proposal for a council recommendation on cancer screening. BMJ 327 (2003), 289–290.
8. Tinmouth, J., Lansdorp-Vogelaar, I., Allison, J.E., Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 64 (2015), 1327–1337.
9. Benson, V.S., Atkin, W.S., Green, J., et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: the international colorectal cancer screening network. Int J Cancer 130 (2012), 2961–2973.
10. Newcomb, P.A., Norfleet, R.G., Storer, B.E., et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84 (1992), 1572–1575.
11. Selby, J.V., Friedman, G.D., Quesenberry, C.P. Jr, Weiss, N.S., A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992), 653–657.
12. Winawer, S.J., Zauber, A.G., Ho, M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993), 1977–1981.
13. Shapiro, J.A., Klabunde, C.N., Thompson, T.D., et al. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 21 (2012), 895–904.
14. Stock, C., Ihle, P., Schubert, I., et al. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort. Endoscopy 43 (2011), 771–781.
15. Anderson, J.C., Alpern, Z., Messina, C.R., et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 99 (2004), 472–477.
16. Imperiale, T.F., Wagner, D.R., Lin, C.Y., Larkin, G.N., Rogge, J.D., Ransohoff, D.F., Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343 (2000), 169–174.
17. Atkin, W.S., Edwards, R., Kralj-Hans, I., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375 (2010), 1624–1633.
18. Hoff, G., Grotmol, T., Skovlund, E., et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ, 338, 2009, b1846.
19. Holme, Ø., Løberg, M., Kalager, M., et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 312 (2014), 606–615.
20. Schoen, R.E., Pinsky, P.F., Weissfeld, J.L., et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366 (2012), 2345–2357.
21. Segnan, N., Armaroli, P., Bonelli, L., et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial—SCORE. J Natl Cancer Inst 103 (2011), 1310–1322.
22. Baxter, N.N., Goldwasser, M.A., Paszat, L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009), 1–8.
23. Demers, A.A., Kliewer, E.V., Mahmud, S.M., et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139 (2010), 1128–1137.
24. Josh, L., Paszat, L.F., Refik, S., et al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 6 (2008), 1117–1121.
25. Singh, H., Nugent, Z., Mahmud, S.M., et al. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 105 (2010), 663–673.
26. Baxter, N.N., Warren, J., Barrett, M.J., et al. The association between colonoscopy and colorectal cancer mortality in a U.S. cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 30 (2012), 2664–2669.
27. Müller, A.D., Sonnenberg, A., Protection by endoscopy against death from colorectal cancer: a case-control study among veterans. Arch Intern Med 155 (1995), 1741–1748.
28. DerSimonian, R., Nan, L., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
29. Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002), 1539–1558.
30. Egger, M., Smith, G.D., Schneider, M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
31. Salanti, G., Higgins, J.P., Ades, A.E., et al. Evaluation of networks of randomized trials. Stat Methods Med Res 17 (2007), 279–301.
32. Jørgensen, O.D., Kronborg, O., Fenger, C., A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50 (2002), 29–32.
33. Lindholm, E., Brevinge, H., Haglind, E., Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 95 (2008), 1029–1036.
34. Scholefield, J.H., Moss, S.M., Mangham, C.M., et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 61 (2012), 1036–1040.
35. Shaukat, A., Mongin, S.J., Geisser, M.S., et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 369 (2013), 1106–1114.
36. Malila, N., Hakama, M., Pukkala, E., A 25-year follow-up of a population screened with faecal occult blood test in Finland. Acta Oncol 46 (2007), 1103–1106.
37. Libby, G., Brewster, D.H., Mcclements, P.L., et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer 107 (2012), 255–259.
38. Hiwatashi, N., Morimoto, T., Fukao, A., et al. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study. Jpn J Cancer Res 84 (1993), 1110–1112.
39. Selby, J.V., Friedman, G.D., Quesenberry, C.P. Jr, Weiss, N.S., Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 118 (1993), 1–6.
40. Lazovich, D., Weiss, N.S., Stevens, N.G., et al. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen 2 (1995), 84–89.
41. Zappa, M., Castiglione, G., Grazzini, G., et al. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 73 (1997), 208–210.
42. Bertario, L., Russo, A., Crosignani, P., et al. Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study. Eur J Cancer 35 (1999), 973–977.
43. Faivre, J., Tazi, M.A., El Mrini, T., Lejeune, C., Benhamiche, A.M., Dassonville, F., Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 79 (1999), 680–683.
44. Hamza, S., Cottet, V., Touillon, N., et al. Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer. Dig Liver Dis 46 (2014), 1121–1125.
45. Holme, O., Bretthauer, M., Fretheim, A., et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 9 (2013), 33–46.
46. Pitkäniemi, J., Seppä, K., Hakama, M., et al. Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland. BMJ Open Gastroenterol, 2, 2015, e000034.
47. Kronborg, O., Fenger, C., Olsen, J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996), 1467–1471.
48. Hardcastle, J.D., Chamberlain, J.O., Robinson, M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996), 1472–1477.
49. Lee, K.J., Inoue, M., Otani, T., et al. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev 31 (2007), 3–11.
50. Chiu, H.M., Chen, L.S., Yen, M.F., et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 121 (2015), 3221–3229.
51. Saito, H., Soma, Y., Koeda, J., et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 61 (1995), 465–469.
52. Ventura, L., Mantellini, P., Grazzini, G., et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 46 (2014), 82–86.
53. Thiis-Evensen, E., Hoff, G.S., Sauar, J., et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 34 (1999), 414–420.
54. Shroff, J., Thosani, N., Batra, S., Singh, H., Guha, S., Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. World J Gastroenterol 20 (2014), 18466–18476.
55. Senore, C., Bonelli, L., Sciallero, S., et al. Assessing generalizability of the findings of sigmoidoscopy screening trials: the case of SCORE trial. J Natl Cancer Inst 107 (2014), 360–361.
56. Kahi, C.J., Imperiale, T.F., Juliar, B.E., et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 7 (2009), 770–775.
57. Jacob, B., Moineddin, R., Sutradhar, R., et al. Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc, 76, 2012, 12.
58. Manser, C.N., Bachmann, L.M., Brunner, J., et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 76 (2012), 110–117.
59. Stock, D., Paszat, L.F., Rabeneck, L., Colorectal cancer mortality reduction is associated with having atleast 1 colonoscopy within the previous 10 years among a population-wide cohort of screening age. Gastrointest Endosc 84 (2016), 133–141.
60. Stock, D., Paszat, L.F., Rabeneck, L., Colorectal cancer mortality reduction associated with having at least 1 colonoscopy within the past 10 years among a population-wide cohort of screening age. Gastrointest Endosc 15 (2016), 721–739.
61. Corder, A.P., Iqbal, M., Devaraj, S., Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036). Br J Surg 95 (2008), 1428–1429 author reply 9.
62. Mandel, J.S., Church, T.R., Bond, J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 344 (2001), 1022–1023.
63. Burch, J.A., Soaresweiser, K., St John, D.J., et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 14 (2007), 132–137.
64. Whitlock, E.P., Lin, J.S., Liles, E., et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 149 (2008), 638–658.
65. Zauber, A.G., Winawer, S.J., O'Brien, M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 (2012), 687–696.
66. Saito, H., Screening for colorectal cancer: current status in Japan. Dis Colon Rectum 43 (2000), S78–S84.
67. Klabunde, C.N., Lanier, D., Nadel, M.R., et al. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med 37 (2009), 8–16.
68. Meissner, H.I., Breen, N., Klabunde, C.N., et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15 (2006), 389–394.
69. Elmunzer, B.J., Singal, A.G., Sussman, J.B., et al. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc 81 (2015), 700–709.